Showing results (421-430 of 499) with videos related to

Sort By:
Pageof 50
Cell Communication and Signaling : CCS|May 13, 2025
RYBP promotes HIV-1 latency through promoting H2AK119ub and decreasing H3K4me3Xinyi Yang, Yuqi Zhu, Xiaying Zhao, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune EnhancementWen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, et al.
Organic & Biomolecular Chemistry|December 18, 2015
A stereo configuration-activity study of 3-iodo-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(2H)-ones as potency inhibitors of HIV-1 variantsShaotong Wu, Qianqian Yin, Liang Zhao, et al.
Journal of Medicinal Chemistry|August 27, 2014
Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeuticsChao Wang, Lu Lu, Heya Na, et al.
Journal of Immunological Methods|November 3, 2006
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningMei-Yun Zhang, Vidita Choudhry, Igor A Sidorov, et al.
Journal of Medicinal Chemistry|January 31, 2012
Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profileXiaowei Wang, Jianfang Zhang, Yang Huang, et al.
Journal of Medicinal Chemistry|April 30, 2021
Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus InfectionChao Wang, Shuai Xia, Xinling Wang, et al.
Cell Research|April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Meiqin Liu, Chao Wang, et al.
Medcomm|July 8, 2025
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron SubvariantsGuangxu Zhang, Qian Wang, Kai Ji, et al.
AIDS (London, England)|May 16, 2018
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cellsDesheng Kong, Yan Wang, Ping Ji, et al.
Pageof 50